Clinical Trial Update: Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating natural dendritic cells for immunotherapy in chemo-naive metastatic castration-resistant prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Radboud University Medical Center | Conditions: Prostatic Neoplasms, Immunotherapy | Phase 2 | Status: COMPLETED